VIPoma interventions

VIPoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating VIPoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

VIPoma interventions On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of VIPoma interventions

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on VIPoma interventions

CDC on VIPoma interventions

VIPoma interventions in the news

Blogs on VIPoma interventions

Directions to Hospitals Treating VIPoma

Risk calculators and risk factors for VIPoma interventions

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief:  Homa Najafi, M.D.[2]

## Overview

[edit | edit source]

The mainstay of treatment for VIPoma is surgery. Hepatic artery embolization or transcatheter chemoembolization with doxorubicin or cisplatin is usually reserved for patients with liver metastases. Moreover, in patients with liver metastases less than 3 cm radiofrequency ablation and cryoablation can be used.

## Indications

[edit | edit source]

The mainstay of treatment for VIPoma is surgery. Hepatic artery embolization or transcatheter chemoembolization with doxorubicin or cisplatin is usually reserved for patients with liver metastases. Moreover, in patients with liver metastases less than 3 cm radiofrequency ablation and cryoablation can be used.[1][2]

## References

[edit | edit source]

1. ↑ Julie King, Richard Quinn, Derek M. Glenn, Julia Janssen, Denise Tong, Winston Liaw & David L. Morris (2008). "Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases". Cancer. 113 (5): 921–929. doi:10.1002/cncr.23685. PMID 18618495. Unknown parameter `|month=` ignored (help)CS1 maint: Multiple names: authors list (link)
2. ↑ Moug, Susan J.; Leen, Edward; Horgan, Paul G.; Imrie, Clement W. (2006). "Radiofrequency Ablation Has a Valuable Therapeutic Role in Metastatic VIPoma". Pancreatology. 6 (1–2): 155–159. doi:10.1159/000090257. ISSN 1424-3903.

Template:WH Template:WS